Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Controlled Trial of Finerenone Therapy for Pediatric Hennoch Scholein Nephritis With Mild Proteinuria

NCT07315191 is registered in ClinicalTrials.gov with Capital Institute of Pediatrics, China as lead sponsor.

NCT NCT07315191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07315191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Controlled Trial of Finerenone Therapy for Pediatric Hennoch Scholein Nephritis With Mild Proteinuria
Lead sponsor
Capital Institute of Pediatrics, China
Phase
Phase 4
Overall status
Recruiting
Start date
June 13, 2025
Completion date
April 30, 2028
Enrollment
116 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

henoch schönlein purpura nephritis